Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia-Reference-Cited by-同舟云学术

Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia

Published:2010-05 Issue:6 Volume:64 Page:727-738
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:

Author:

Shah S.,Ceska R.,Gil-Extremera B.,Paolini J. F.,Giezek H.,Vandormael K.,Mao A.,McCrary Sisk C.,Maccubbin D.

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-1241.2010.02370.x/fullpdf

Reference33 articles.

1. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;J Am Coll Cardiol,2004

2. Prevalence and predictors of lipid abnormalities in patients treated with statins in the UK general;Phatak;Atheresclerosis,2009

3. Impact of new Joint British Societies’ (JBS 2) guidelines on prevention of cardiovascular disease: evaluation of serum total cholesterol goal achievement in UK clinical practice;Rajagopalan;Curr Med Res Opin,2007

4. Mixed dyslipidemia among patients using lipid lowering therapy in French general practice: an observational study;Van Ganse;Clin Ther,2007

5. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report;National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);Circulation,2002

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in glucose metabolism, C-reactive protein, and liver enzymes following intake of NAD + precursor supplementation: a systematic review and meta‐regression analysis;Nutrition & Metabolism;2024-06-24

2. Effects of NAD+ precursors on blood pressure, C‐reactive protein concentration and carotid intima‐media thickness: A meta‐analysis of randomized controlled trials;European Journal of Clinical Investigation;2023-08-18

3. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease, the Impact of Available Lipid-Lowering Medications on Lipoprotein(a): An Update on New Therapies;Endocrine Practice;2022-12

4. Ensayos clínicos. Una asignatura pendiente;Revista Clínica Española;2018-04

5. Clinical trials. A pending subject;Revista Clínica Española (English Edition);2018-04